ENTRY       D11712                      Drug
NAME        Pralsetinib (USAN/INN);
            Gavreto (TN)
PRODUCT     GAVRETO (Genentech)
FORMULA     C27H32FN9O2
EXACT_MASS  533.2663
MOL_WEIGHT  533.6005
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
REMARK      ATC code: L01EX23
            Chemical structure group: DG03223
            Product (DG03223): D11712<US>
EFFICACY    Antineoplastic, Tyrosine kinase inhibitor
  DISEASE   Non-small cell lung cancer (RET fusion positive) [DS:H00014]
            Medullary thyroid cancer (RET mutant) [DS:H01592]
            Thyroid cancer (RET fusion positive) [DS:H00032]
COMMENT     Treatment of RET-driven malignacies
TARGET      RET* [HSA_VAR:5979v1] [HSA:5979] [KO:K05126]
  PATHWAY   hsa05200(5979)  Pathways in cancer
            hsa05223(5979)  Non-small cell lung cancer
            hsa05230(5979)  Central carbon metabolism in cancer
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EX Other protein kinase inhibitors
                 L01EX23 Pralsetinib
                  D11712  Pralsetinib (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Pralsetinib
                D11712  Pralsetinib (USAN/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG03223  Pralsetinib
                D11712  Pralsetinib
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               RET family
                RET* [HSA_VAR:5979v1]
                 D11712  Pralsetinib (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11712
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11712
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D11712
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG03223  Pralsetinib
DBLINKS     CAS: 2097132-94-8
            PubChem: 405226578
ATOM        39
            1   C8y C    24.0100  -15.2600
            2   N5x N    24.0100  -13.8600
            3   C8x C    22.8200  -13.1600
            4   C8y C    21.5600  -13.8600
            5   C8x C    21.5600  -15.2600
            6   C8x C    22.8200  -15.9600
            7   N4y N    25.2000  -15.9600
            8   C8x C    25.2000  -17.3600
            9   C8y C    26.4600  -17.8500
            10  C8x C    27.3700  -16.7300
            11  N5x N    26.5300  -15.6100
            12  X   F    26.8800  -19.1800
            13  C1c C    20.3700  -13.1600
            14  N1b N    19.1800  -13.8600
            15  C1a C    20.3700  -11.7600
            16  C5a C    17.9900  -13.1600
            17  C1z C    16.8000  -13.8600
            18  O5a O    17.9900  -11.7600
            19  C1x C    15.6100  -13.1600
            20  C1x C    14.3500  -13.8600
            21  C1y C    14.3500  -15.2600
            22  C1x C    15.5400  -15.9600
            23  C1x C    16.8000  -15.2600
            24  O2a O    16.8000  -12.4600
            25  C1a C    15.6100  -11.7600
            26  C8y C    13.1600  -15.9600
            27  N5x N    11.9700  -15.2600
            28  C8y C    10.7100  -15.9600
            29  C8x C    10.7100  -17.3600
            30  C8y C    11.9000  -18.0600
            31  N5x N    13.1600  -17.3600
            32  C1a C    11.9000  -19.4600
            33  N1b N     9.5200  -15.2600
            34  C8y C     8.3300  -15.9600
            35  N5x N     7.0000  -15.5400
            36  N4x N     6.1600  -16.6600
            37  C8y C     7.0000  -17.7800
            38  C8x C     8.3300  -17.3600
            39  C1a C     6.5800  -19.0400
BOND        43
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 1
            9     8   9 2
            10    9  10 1
            11   10  11 2
            12    7  11 1
            13    9  12 1
            14    4  13 1
            15   13  14 1
            16   13  15 1 #Up
            17   14  16 1
            18   16  17 1
            19   16  18 2
            20   17  19 1
            21   19  20 1
            22   20  21 1
            23   21  22 1
            24   22  23 1
            25   17  23 1
            26   17  24 1 #Down
            27   24  25 1
            28   21  26 1 #Down
            29   26  27 2
            30   27  28 1
            31   28  29 2
            32   29  30 1
            33   30  31 2
            34   26  31 1
            35   30  32 1
            36   28  33 1
            37   33  34 1
            38   34  35 2
            39   35  36 1
            40   36  37 1
            41   37  38 2
            42   34  38 1
            43   37  39 1
///
